News
Know More About Singclean
Singclean to Showcase Aesthetic Manufacturing Excellence and Singderm Brand Strength at IMCAS 2026
singclean | 2026-01-21

5d931f5503b8af092d9e5af3344f96bc.png


Paris, France | January 29–31, 2026
Palais des Congrès de Paris
Booth No.: H122, Level 1, Hall Passy C


Singclean Medical will participate in IMCAS World Congress 2026, one of the world’s leading events in dermatology and aesthetic medicine, to present its advanced aesthetic manufacturing capabilities and the global development of its medical aesthetics brand, Singderm.


At Booth H122 (Level 1, Hall Passy C), Singclean will showcase its comprehensive portfolio of aesthetic injectable solutions, including dermal fillers, biostimulators, and skin regeneration products. With over 20 years of expertise in absorbable biomaterials, Singclean operates one of Asia’s largest automated cross-linked hyaluronic acid (HA) gel production workshops, ensuring consistent quality, scalable supply, and strong compliance with international standards.


A key highlight will be Singderm, Singclean’s dedicated aesthetics brand, which has established a solid presence across Asia, South America, and Europe. Supported by strong R&D capabilities and an integrated manufacturing platform, Singderm continues to gain market recognition through reliable product performance, localized strategies, and long-term partnerships with global distributors and aesthetic professionals.


Through IMCAS 2026, Singclean aims to strengthen international collaboration, engage with global industry leaders, and further expand its footprint in the global medical aesthetics market.


Visitors are welcome to meet the Singclean team at Booth H122 and explore future opportunities in aesthetic medicine.